StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.12−0.06 (-1.89%)

Close on Nov 18, 2026Market cap $777.47MP/E –Yield –

Ardelyx net income

Net income is the profit left for shareholders after every expense, interest and tax.

Ardelyx's net income for the twelve months ending Jun 30, 2026 was -$55.70M. For fiscal 2025 it was -$61.60M. The highest annual figure on record is -$3.21M in fiscal 2014.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$61.60M–
FY2024Dec 31, 2024-$39.14M–
FY2023Dec 31, 2023-$66.07M–
FY2022Dec 31, 2022-$67.21M–
FY2021Dec 31, 2021-$158.17M–
FY2020Dec 31, 2020-$94.31M–
FY2019Dec 31, 2019-$94.94M–
FY2018Dec 31, 2018-$91.30M–
FY2017Dec 31, 2017-$64.34M–
FY2016Dec 31, 2016-$112.39M–
FY2015Dec 31, 2015-$29.62M–
FY2014Dec 31, 2014-$3.21M–
FY2013Dec 31, 2013-$6.56M–
FY2012Dec 31, 2012-$9.79M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$16.72M–
Q1 FY2026Mar 31, 2026-$37.61M–
Q4 FY2025Dec 31, 2025-$407.00K-108.8%
Q3 FY2025Sep 30, 2025-$969.00K–
Q2 FY2025Jun 30, 2025-$19.08M–
Q1 FY2025Mar 31, 2025-$41.14M–
Q4 FY2024Dec 31, 2024$4.65M–
Q3 FY2024Sep 30, 2024-$809.00K-112.2%
Q2 FY2024Jun 30, 2024-$16.45M–
Q1 FY2024Mar 31, 2024-$26.52M–
Q4 FY2023Dec 31, 2023-$28.80M-369.3%
Q3 FY2023Sep 30, 2023$6.63M–
Q2 FY2023Jun 30, 2023-$17.12M–
Q1 FY2023Mar 31, 2023-$26.77M–
Q4 FY2022Dec 31, 2022$10.70M–
Q3 FY2022Sep 30, 2022-$22.89M–
Q2 FY2022Jun 30, 2022-$26.94M–
Q1 FY2022Mar 31, 2022-$28.07M–
Q4 FY2021Dec 31, 2021-$36.23M–
Q3 FY2021Sep 30, 2021-$43.59M–
Q2 FY2021Jun 30, 2021-$45.19M–
Q1 FY2021Mar 31, 2021-$33.16M–
Q4 FY2020Dec 31, 2020-$28.88M–
Q3 FY2020Sep 30, 2020-$18.11M–
Q2 FY2020Jun 30, 2020-$24.96M–
Q1 FY2020Mar 31, 2020-$22.37M–
Q4 FY2019Dec 31, 2019-$19.79M–
Q3 FY2019Sep 30, 2019-$23.54M–
Q2 FY2019Jun 30, 2019-$25.47M–
Q1 FY2019Mar 31, 2019-$26.14M–
Q4 FY2018Dec 31, 2018-$27.86M-375.5%
Q3 FY2018Sep 30, 2018-$24.13M–
Q2 FY2018Jun 30, 2018-$22.29M–
Q1 FY2018Mar 31, 2018-$17.02M–
Q4 FY2017Dec 31, 2017$10.11M–
Q3 FY2017Sep 30, 2017-$20.72M–
Q2 FY2017Jun 30, 2017-$25.72M–
Q1 FY2017Mar 31, 2017-$28.01M–
Q4 FY2016Dec 31, 2016-$31.28M–
Q3 FY2016Sep 30, 2016-$29.03M–

More Ardelyx figures

See a number that looks wrong?